Antiviral trial ties valacyclovir to faster cognitive decline

New York State Psychiatric Institute and Columbia University Medical Center investigators, with co-authors across additional US centers, report greater cognitive worsening at 78 weeks with valacyclovir than with placebo among adults with early…

Continue Reading

News Source: medicalxpress.com